Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
112M
-
Number of holders
-
163
-
Total 13F shares, excl. options
-
62M
-
Shares change
-
+20.3M
-
Total reported value, excl. options
-
$1.57B
-
Value change
-
+$517M
-
Put/Call ratio
-
0.71
-
Number of buys
-
111
-
Number of sells
-
-56
-
Price
-
$25.35
Significant Holders of Evolent Health, Inc. - Class A Common Stock (EVH) as of Q2 2017
189 filings reported holding EVH - Evolent Health, Inc. - Class A Common Stock as of Q2 2017.
Evolent Health, Inc. - Class A Common Stock (EVH) has 163 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 62M shares
of 112M outstanding shares and own 55.52% of the company stock.
Largest 10 shareholders include FMR LLC (9.86M shares), JPMORGAN CHASE & CO (5.44M shares), VANGUARD GROUP INC (3.77M shares), BlackRock Inc. (2.41M shares), RIVERBRIDGE PARTNERS LLC (2.32M shares), Invesco Ltd. (2.3M shares), Pennant Capital Management, LLC (2.2M shares), BLAIR WILLIAM & CO/IL (2.19M shares), COLUMBIA WANGER ASSET MANAGEMENT LLC (2M shares), and MILLENNIUM MANAGEMENT LLC (1.63M shares).
This table shows the top 163 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.